Abstract
The relevance of the study is due to the need for intensive implementation of innovative projects in the field of high-tech medicine and biotechnology, the formed demand from large non-core industrial companies, investments of which are attracted for the implementation of these science and money-intensive areas. Subject of research: non-core investment activities of large industrial companies in innovative biotechnology projects. Objective: formation of approaches to the management of the process of search, selection, expertise and implementation of innovative projects in the field of high-tech healthcare and biotechnology, potentially economically profitable and suitable for scaling by Russian companies. Scientific novelty is determined by the development of new methods, technologies and approaches to managing the process of search, selection, expertise and implementation of innovative projects in the field of high-tech medicine and biotechnology, potentially economically profitable and suitable for scaling by large non-core industrial companies. The research was conducted in 2022, at RANEPA, using a set of analytical methods, questionnaires and programming. Methods: observation; surveying, system analysis, socio-economic analysis; comparative legal analysis; multi-agent systems theory; formal analysis of historical phenomena; elements of expert systems theory, database creation. Results: The results of the analysis of the existing situation with the real practice of organizing the work of large non-core industrial companies in the search, selection, examination and implementation of innovative projects in the field of high-tech medicine and biotechnology: a summary classifier of the main scientific and practical disciplines in the field of "biotechnology"; a database of innovative projects in the field of high-tech medicine and biotechnology; a form of a Project Sheet submitted for expert evaluation for investment. a base of regulatory normative legal acts; the methodology of the sociological research of organizational approaches of the subjects of the Russian Federation to the development of noncore investments by large industrial companies into innovative projects in the field of development and implementation of medical materials, including biotechnologies. The first results of the sociological research with the proposals from several regions were received. Proposals for the formation of a screening program for preventive laboratory biochemical examination of workers; a business planning procedure for the creation of a multidisciplinary laboratory in the field of biotechnology; methodological recommendations for the examination of the investment project. Database "Electronic base of terms and definitions in the sphere of biotechnology and medicine". Encyclopedic dictionary reference book "Biotechnology: Medical Aspects". Conclusions: In recent years, the biotechnology industry of various kinds has been actively developing in Russia. However, investment by a large industrial company in biotechnology projects as a non-core activity, especially under conditions of a pandemic and when using the mechanism of sanctions, requires the creation of a special methodological apparatus. In this connection, a number of necessary methodological tools were developed in relation to the tasks of non-core activities of a large industrial company. The results of the implementation by a large industrial company of projects in the field of biotechnology, selected from the position of social efficiency and investment attractiveness, will undoubtedly have a pronounced socio-economic effect. Recommendations: The results obtained within the framework of this research can be used in the process of functioning of legislative and executive authorities of the Russian Federation, implementing their powers in the social sphere for the formation of new mechanisms of state policy in the field of health care and market economy in the conditions of pandemic and restrictive measures of economic nature.
The relevance of the study is due to the need for intensive implementation of innovative projects in the field of high-tech medicine and biotechnology, the formed demand from large non-core industrial companies, investments of which are attracted for the implementation of these [...]